Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Clinical Immunology

Taking Control: Treatment and Daily Management

At a Glance

C1r/C1s deficiency is managed by preventing serious infections with recommended vaccines and, for some people, preventive antibiotics. If lupus develops, immune-suppressing treatment may be needed with close infection precautions and regular kidney monitoring.

Managing C1r/C1s deficiency focuses on two main goals: building a defense against infections and quieting the immune system’s tendency to attack itself [1]. Because this condition is so rare, there is no “one-size-fits-all” pill or targeted replacement therapy available today [2]. Instead, your care team will create an individualized plan based on your specific history and symptoms [1].

Building a Defensive Wall: Vaccinations

Vaccination is the most critical tool for preventing life-threatening infections from “encapsulated” bacteria, such as Streptococcus pneumoniae and Neisseria meningitidis [3][4]. Standard recommendations for people with complement deficiencies include:

  • Meningococcal Vaccines (MenACWY and MenB): You should receive both types of meningitis vaccines. Because schedules and booster intervals differ based on age, prior doses, and vaccine product, you must follow the current national risk-based schedule with your clinician [3][5].
  • Pneumococcal and Hib Vaccines: These protect against important causes of pneumonia, ear infections, and bloodstream infections [4].
  • Routine Vaccines: Staying current with influenza and COVID-19 vaccines is also important to prevent viral illnesses that can compound bacterial risks [6][1].

It is important to know that while vaccines are very helpful, they may not be 100% effective in people with complement defects [7]. You must still seek urgent clinical assessment for emergency warning signs.

Antibiotic Prophylaxis: An Extra Layer

In addition to vaccines, many doctors consider prophylactic antibiotics to prevent infections [8].

  • Who Needs Them?: There is no single regimen required for every person. Decisions depend heavily on your infection history, age, allergies, local resistance, and concurrent immunosuppression [8][1].
  • Common Choices: Penicillin or co-trimoxazole are frequently used in these customized regimens [9].
  • Standby Antibiotics: Some patients are prescribed a “standby” antibiotic. This should be used only under explicit written instructions and must never replace or delay urgent assessment at the hospital [8].

Managing Autoimmunity and Lupus

If the deficiency triggers Systemic Lupus Erythematosus (SLE) or kidney inflammation (lupus nephritis), treatment shifts toward calming the immune system [2].

  • Immunosuppressants: Lupus treatment is selected by rheumatology and nephrology according to organ involvement and current lupus guidance. In limited case reports, medications like rituximab have been used to deplete B cells [2].
  • Balancing Act: Using these medications requires a careful balance, as they treat the lupus but can substantially increase your already elevated infection risk. Infection prevention must be considered alongside any immunosuppression [1].

Treatments That Are Not Routine

It is helpful to clarify what treatments are generally not part of standard care for C1r/C1s deficiency:

  • Fresh Frozen Plasma (FFP): While plasma contains complement proteins, it is not a routine or proven replacement treatment for this deficiency [10].
  • C1-Inhibitor Concentrates: These are used for a different condition called Hereditary Angioedema (HAE) and do not replace the missing C1r or C1s proteins [11][12].

Your management plan will be a lifelong partnership with your medical team. Regular monitoring of your kidney function and staying current with all vaccines are the keys to living safely with this condition [1][2].

Common questions in this guide

Which vaccines are recommended for C1r/C1s deficiency?
People with C1r/C1s deficiency are generally advised to stay up to date with MenACWY and MenB meningococcal vaccines, pneumococcal and Hib vaccines, and routine influenza and COVID-19 vaccines. The exact schedule and booster timing depend on age, previous doses, vaccine product, and current national guidance, so confirm the plan with your clinician.
Do vaccines completely prevent infections in C1r/C1s deficiency?
No. Vaccines lower the risk of serious infections but may not work fully in people with complement deficiencies. Fever or other warning signs of a severe infection still require urgent medical assessment.
Should I take preventive antibiotics for C1r/C1s deficiency?
Some people are prescribed preventive antibiotics, but there is no single regimen that is right for everyone. The decision may depend on your infection history, age, allergies, local antibiotic resistance, and whether you take immune-suppressing medicines; penicillin or co-trimoxazole may be used in customized plans.
When should I use a standby antibiotic?
A clinician may prescribe an antibiotic to keep available for a possible infection, but you should use it only under explicit written instructions. A standby antibiotic must never replace or delay urgent hospital assessment when emergency warning signs are present.
How is lupus treated when someone has C1r/C1s deficiency?
If systemic lupus erythematosus or lupus nephritis develops, rheumatology and nephrology teams choose immune-suppressing treatment based on the organs involved and current lupus guidance. Medicines such as rituximab have been used in limited reports, but immune suppression can raise infection risk, so prevention measures must be coordinated.
How often should kidney function be monitored?
Kidney function should be checked regularly because lupus nephritis can inflame and damage the kidneys. The right interval depends on your lupus status, symptoms, previous test results, and treatment, so your nephrologist or rheumatologist should set the schedule.

Get notified when new evidence is published on complement component C1r/C1s deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (12)
  1. 1

    Immunodeficiency: Complement disorders.

    McMurray JC, Schornack BJ, Weskamp AL, et al.

    Allergy and asthma proceedings 2024; (45(5)):305-309 doi:10.2500/aap.2024.45.240050.

    PMID: 39294906
  2. 2

    Complement C1s deficiency in a male Caucasian patient with systemic lupus erythematosus: a case report.

    Kleer JS, Skattum L, Dubler D, et al.

    Frontiers in immunology 2023; (14()):1257525 doi:10.3389/fimmu.2023.1257525.

    PMID: 38469558
  3. 3

    Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020.

    Mbaeyi SA, Bozio CH, Duffy J, et al.

    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports 2020; (69(9)):1-41 doi:10.15585/mmwr.rr6909a1.

    PMID: 33417592
  4. 4

    Inherited Classical and Alternative Pathway Complement Deficiencies in Children: A Single Center Experience.

    Genel F, Erdem SB, Gülez N, et al.

    Iranian journal of immunology : IJI 2018; (15(4)):309-320 doi:10.22034/IJI.2018.39400.

    PMID: 30593745
  5. 5

    Use of the GSK MenACWY-CRM/MenB-4C Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025.

    Amin AB, Collins JP, Dong X, et al.

    MMWR. Morbidity and mortality weekly report 2026; (75(1)):7-14 doi:10.15585/mmwr.mm7501a2.

    PMID: 41505372
  6. 6

    Vaccination status in patients at risk for invasive disease with encapsulated bacteria at a children's hospital in the City of Buenos Aires.

    Del Pino M, Castellano VE, Pacchiotti AC, et al.

    Archivos argentinos de pediatria 2023; (121(1)):e202202648 doi:10.5546/aap.2022-02648.eng.

    PMID: 36287171
  7. 7

    Meningococcal B Vaccine Immunogenicity in Children With Defects in Complement and Splenic Function.

    Martinón-Torres F, Bernatowska E, Shcherbina A, et al.

    Pediatrics 2018; (142(3)) doi:10.1542/peds.2017-4250.

    PMID: 30068713
  8. 8

    Clinical Outcome and Underlying Genetic Cause of Functional Terminal Complement Pathway Deficiencies in a Multicenter UK Cohort.

    Shears A, Steele C, Craig J, et al.

    Journal of clinical immunology 2022; (42(3)):665-671 doi:10.1007/s10875-022-01213-9.

    PMID: 35084692
  9. 9

    Infections Revealing Complement Deficiency in Adults: A French Nationwide Study Enrolling 41 Patients.

    Audemard-Verger A, Descloux E, Ponard D, et al.

    Medicine 2016; (95(19)):e3548 doi:10.1097/MD.0000000000003548.

    PMID: 27175654
  10. 10

    The Alterations in Methylene Blue/Light-Treated Frozen Plasma Proteins Revealed by Proteomics.

    Wu T, Wang X, Ren K, et al.

    Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie 2021; (48(5)):298-305 doi:10.1159/000515119.

    PMID: 34803573
  11. 11

    Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients.

    Kajdácsi E, Jandrasics Z, Veszeli N, et al.

    Frontiers in immunology 2020; (11()):794 doi:10.3389/fimmu.2020.00794.

    PMID: 32431708
  12. 12

    Parallel comparison of three methodologies for measuring functional C1-inhibitor in Hereditary angioedema patients.

    Kapoor A, Garg BK, Zhou Z, et al.

    International immunopharmacology 2020; (81()):106348 doi:10.1016/j.intimp.2020.106348.

    PMID: 32143147

This page explains infection prevention and autoimmune treatment considerations for C1r/C1s deficiency for informational purposes only and does not replace medical advice. Your immunologist, rheumatologist, and nephrologist should tailor vaccines, antibiotics, and monitoring to your needs.